124 related articles for article (PubMed ID: 38314781)
1. Factors affecting different COVID-19 outcomes in patients with systemic lupus erythematosus during the second pandemic wave of COVID-19 in China.
Liu PC; Zhang M; Li JB; Peng YL; Yu SJ; Wu R
Lupus; 2024 Apr; 33(4):357-364. PubMed ID: 38314781
[TBL] [Abstract][Full Text] [Related]
2. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.
Ugarte-Gil MF; Alarcón GS; Izadi Z; Duarte-García A; Reátegui-Sokolova C; Clarke AE; Wise L; Pons-Estel GJ; Santos MJ; Bernatsky S; Ribeiro SLE; Al Emadi S; Sparks JA; Hsu TY; Patel NJ; Gilbert EL; Valenzuela-Almada MO; Jönsen A; Landolfi G; Fredi M; Goulenok T; Devaux M; Mariette X; Queyrel V; Romão VC; Sequeira G; Hasseli R; Hoyer B; Voll RE; Specker C; Baez R; Castro-Coello V; Maldonado Ficco H; Reis Neto ET; Ferreira GAA; Monticielo OAA; Sirotich E; Liew J; Hausmann J; Sufka P; Grainger R; Bhana S; Costello W; Wallace ZS; Jacobsohn L; Taylor T; Ja C; Strangfeld A; Mateus EF; Hyrich KL; Carmona L; Lawson-Tovey S; Kearsley-Fleet L; Schäfer M; Machado PM; Robinson PC; Gianfrancesco M; Yazdany J
Ann Rheum Dis; 2022 Jul; 81(7):970-978. PubMed ID: 35172961
[TBL] [Abstract][Full Text] [Related]
3. Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus.
Bruera S; Lei X; Zhao H; Yazdany J; Chavez-MacGregor M; Giordano SH; Suarez-Almazor ME
Lupus Sci Med; 2023 Feb; 10(1):. PubMed ID: 36787921
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
Scirocco C; Ferrigno S; Andreoli L; Fredi M; Lomater C; Moroni L; Mosca M; Raffeiner B; Carrara G; Landolfi G; Rozza D; Zanetti A; Scirè CA; Sebastiani GD
Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37848262
[TBL] [Abstract][Full Text] [Related]
5. Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance.
Ugarte-Gil MF; Alarcón GS; Seet AM; Izadi Z; Montgomery AD; Duarte-García A; Gilbert EL; Valenzuela-Almada MO; Wise L; Sparks JA; Hsu TY; D'Silva KM; Patel NJ; Sirotich E; Liew JW; Hausmann JS; Sufka P; Grainger R; Bhana S; Wallace Z; Jacobsohn L; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Lawson-Tovey S; Kearsley-Fleet L; Schaefer M; Machado PM; Robinson PC; Gianfrancesco M; Yazdany J
Arthritis Care Res (Hoboken); 2023 Jan; 75(1):53-60. PubMed ID: 36239292
[TBL] [Abstract][Full Text] [Related]
6. Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management.
Mehta P; Gasparyan AY; Zimba O; Kitas GD
Clin Rheumatol; 2022 Sep; 41(9):2893-2910. PubMed ID: 35639259
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for severe COVID-19 among patients with systemic lupus erythematosus: a real-world analysis of a large representative US administrative claims database, 2020-2021.
Calabrese C; Atefi G; Evans KA; Moynihan M; Palmer L; Wu SJ
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37591618
[TBL] [Abstract][Full Text] [Related]
8. Systemic Lupus Erythematosus and COVID-19.
Pappa M; Panagiotopoulos A; Thomas K; Fanouriakis A
Curr Rheumatol Rep; 2023 Oct; 25(10):192-203. PubMed ID: 37477841
[TBL] [Abstract][Full Text] [Related]
9. Latent Tuberculosis Infection and Associated Factors in Patients with Systemic Lupus Erythematosus: a Multicenter, Cross-Sectional Study.
Zhang L; Ma Y; Jiang N; Zou X; Zhang Y; Zhang F; Zeng X; Zhao Y; Liu S; Zuo X; Wu H; Wu L; Li H; Zhang Z; Chen S; Zhu P; Zhang M; Qi W; Liu Y; Liu H; Shi X; Liu X
Microbiol Spectr; 2023 Jun; 11(3):e0084823. PubMed ID: 37158726
[TBL] [Abstract][Full Text] [Related]
10. Lupus, vaccinations and COVID-19: What we know now.
Mason A; Anver H; Lwin M; Holroyd C; Faust SN; Edwards CJ
Lupus; 2021 Sep; 30(10):1541-1552. PubMed ID: 34134555
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Vaccine Uptake Among Patients With Systemic Lupus Erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN).
Chevet B; Figueroa-Parra G; Yang JX; Hulshizer CA; Gunderson TM; Duong SQ; Putman MS; Barbour KE; Crowson CS; Duarte-García A
J Rheumatol; 2022 Nov; 49(11):1276-1282. PubMed ID: 35777817
[TBL] [Abstract][Full Text] [Related]
12. Post-COVID-19 depression and anxiety in patients with systemic lupus erythematosus.
Abd El-Khalik DM; Eltohamy M
Lupus; 2023 Jul; 32(8):974-982. PubMed ID: 37283176
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis.
Akhlaq A; Aamer S; Hasan KM; Muzammil TS; Sohail AH; Quazi MA; Khan MS; Sheikh AB
Lupus; 2024 Mar; 33(3):248-254. PubMed ID: 38194931
[TBL] [Abstract][Full Text] [Related]
14. Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
Mok CC; Chan KL; Tse SM
Vaccine; 2022 Sep; 40(41):5959-5964. PubMed ID: 36085256
[TBL] [Abstract][Full Text] [Related]
15. Health Care-Seeking Behaviors, Disease Progression, Medications, Knowledge of, and Attitudes Toward Systemic Lupus Erythematosus in China: Cross-sectional Survey Study.
Dai Z; Huang X; Yuan F; Li T; Xie B; Lin H; Yang P; Li X; Xu S; Zhao J; Wang Y; Peng X; Wei S; Huang W; Li J; Liang J; Liu X; Chu Y; Zhang Z; Zhang R; Lau EHY; Lin Z
JMIR Public Health Surveill; 2023 Apr; 9():e44541. PubMed ID: 37027203
[TBL] [Abstract][Full Text] [Related]
16. Impact of SARS-CoV-2 infection on patients with systemic lupus erythematosus in England prior to vaccination: a retrospective observational cohort study.
Rabe APJ; Loke WJ; Kalyani RN; Tummala R; Stirnadel-Farrant HA; Were J; Winthrop KL
BMJ Open; 2023 Nov; 13(11):e071072. PubMed ID: 37993165
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes.
Pastore DEA; Costa ML; Surita FG
Lupus; 2019 Oct; 28(12):1417-1426. PubMed ID: 31551036
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 in patients with systemic lupus erythematosus: A systematic review.
Fu XL; Qian Y; Jin XH; Yu HR; Du L; Wu H; Chen HL; Shi YQ
Lupus; 2022 May; 31(6):684-696. PubMed ID: 35382637
[TBL] [Abstract][Full Text] [Related]
19. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
[TBL] [Abstract][Full Text] [Related]
20. Attitudes towards and safety of the SARS-CoV-2 inactivated vaccines in 188 patients with systemic lupus erythematosus: a post-vaccination cross-sectional survey.
Tang Q; Li F; Tian J; Kang J; He J
Clin Exp Med; 2023 Jun; 23(2):457-463. PubMed ID: 35612692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
